|Articles|September 1, 2003
Not Doing the Job
Author(s)Beth Kapes
Barcelona - With a view on managing alopecia areata that is in complete contrast to the position commonly taken in the United States, Rudolf Happle, M.D., brings forward an interesting question: Why do dermatologists continue to use topical corticosteroids [and other treatments] if they are not truly effective in treating all forms of AA?
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
3
Phase 2 Nemolizumab Trial Opens for CPUO
4
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
5
